| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |